Carl Genberg
Direttore Tecnico/Scientifico/R&S presso Ceragenix Corp.
Profilo
Carl Genberg currently works at Ceragenix Corp., as Senior Vice President-Research & Development from 2002.
Mr. Genberg also formerly worked at N8 Medical, Inc., as Chief Executive Officer, OnSource Corp., as Senior Vice President, and Ceragenix Pharmaceuticals, Inc., as SVP-Research & Development from 2005 to 2010.
Mr. Genberg received his undergraduate degree from Cornell University.
Posizioni attive di Carl Genberg
| Società | Posizione | Inizio |
|---|---|---|
| Ceragenix Corp. | Direttore Tecnico/Scientifico/R&S | 01/02/2002 |
Precedenti posizioni note di Carl Genberg
| Società | Posizione | Fine |
|---|---|---|
N8 Medical, Inc.
 N8 Medical, Inc. Medical SpecialtiesHealth Technology N8 Medical, Inc. is an American clinical stage biotechnology company that develops anti-fouling medical devices to reduce infections, complications, and mortality. The private company is based in an undisclosed location and has a platform technology called Cerashield™, which is based on ceragenins, a novel compound invented by Professor Paul B. Savage. The technology has been featured in over 90 peer-reviewed journal articles. Marc H. Rohman has been the CEO of the company since 2019. | Amministratore Delegato | 01/06/2019 |
Ceragenix Pharmaceuticals, Inc.
 Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO. | Direttore Tecnico/Scientifico/R&S | 29/03/2010 |
| OnSource Corp. | Corporate Officer/Principal | 27/06/2005 |
Formazione di Carl Genberg
| Cornell University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
| OnSource Corp. | Consumer Services |
Ceragenix Pharmaceuticals, Inc.
Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO. | Health Technology |
| Ceragenix Corp. | |
N8 Medical, Inc.
N8 Medical, Inc. Medical SpecialtiesHealth Technology N8 Medical, Inc. is an American clinical stage biotechnology company that develops anti-fouling medical devices to reduce infections, complications, and mortality. The private company is based in an undisclosed location and has a platform technology called Cerashield™, which is based on ceragenins, a novel compound invented by Professor Paul B. Savage. The technology has been featured in over 90 peer-reviewed journal articles. Marc H. Rohman has been the CEO of the company since 2019. | Health Technology |
- Borsa valori
- Insiders
- Carl Genberg